Outcome and prognostic factors in medically treated canine prostatic carcinomas: A multi‐institutional study

Literature describing medical treatment of canine prostatic carcinoma (PC) is sparse. The aims of this study were to assess outcomes, including time to progression (TTP) and median survival time (MST), of canine PC treated with non‐steroidal anti‐inflammatory drugs (NSAIDs) and/or chemotherapy, and...

Full description

Saved in:

Bibliographic Details
Published in:	Veterinary & comparative oncology Vol. 16; no. 4; pp. 450 - 458
Main Authors:	Ravicini, S., Baines, S. J., Taylor, A., Amores‐Fuster, I., Mason, S. L., Treggiari, E.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-12-2018
Subjects:	Animals Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Carcinoma - diagnosis Carcinoma - drug therapy Carcinoma - mortality Carcinoma - veterinary chemotherapy dog Dog Diseases - diagnosis Dog Diseases - drug therapy Dog Diseases - mortality Dogs Drug Therapy, Combination - veterinary Male medical treatment NSAIDs Prognosis prostatic carcinoma Prostatic Neoplasms - diagnosis Prostatic Neoplasms - drug therapy Prostatic Neoplasms - mortality Prostatic Neoplasms - veterinary Retrospective Studies Treatment Outcome prostatic carcinoma medical treatment chemotherapy dog NSAIDs
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!